Cargando…

Transfusion of CXCR4-Primed Endothelial Progenitor Cells Reduces Cerebral Ischemic Damage and Promotes Repair in db/db Diabetic Mice

This study investigated the role of stromal cell-derived factor-1α (SDF-1α)/CXC chemokine receptor 4 (CXCR4) axis in brain and endothelial progenitor cells (EPCs), and explored the efficacy of CXCR4 primed EPCs in treating ischemic stroke in diabetes. The db/db diabetic and db/+ mice were used in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ji, Chen, Jianying, Chen, Shuzhen, Zhang, Cheng, Zhang, Liangqing, Xiao, Xiang, Das, Avik, Zhao, Yuhui, Yuan, Bin, Morris, Mariana, Zhao, Bin, Chen, Yanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503762/
https://www.ncbi.nlm.nih.gov/pubmed/23185548
http://dx.doi.org/10.1371/journal.pone.0050105
_version_ 1782250502809976832
author Chen, Ji
Chen, Jianying
Chen, Shuzhen
Zhang, Cheng
Zhang, Liangqing
Xiao, Xiang
Das, Avik
Zhao, Yuhui
Yuan, Bin
Morris, Mariana
Zhao, Bin
Chen, Yanfang
author_facet Chen, Ji
Chen, Jianying
Chen, Shuzhen
Zhang, Cheng
Zhang, Liangqing
Xiao, Xiang
Das, Avik
Zhao, Yuhui
Yuan, Bin
Morris, Mariana
Zhao, Bin
Chen, Yanfang
author_sort Chen, Ji
collection PubMed
description This study investigated the role of stromal cell-derived factor-1α (SDF-1α)/CXC chemokine receptor 4 (CXCR4) axis in brain and endothelial progenitor cells (EPCs), and explored the efficacy of CXCR4 primed EPCs in treating ischemic stroke in diabetes. The db/db diabetic and db/+ mice were used in this study. Levels of plasma SDF-1α and circulating CD34+CXCR4+ cells were measured. Brain SDF-1α and CXCR4 expression were quantified at basal and after middle cerebral artery occlusion (MCAO). In in vitro study, EPCs were transfected with adenovirus carrying null (Ad-null) or CXCR4 (Ad-CXCR4) followed with high glucose (HG) treatment for 4 days. For pathway block experiments, cells were pre-incubated with PI3K inhibitor or nitric oxide synthase (NOS) inhibitor for two hours. The CXCR4 expression, function and apoptosis of EPCs were determined. The p-Akt/Akt and p-eNOS/eNOS expression in EPCs were also measured. In in vivo study, EPCs transfected with Ad-null or Ad-CXCR4 were infused into mice via tail vein. On day 2 and 7, the cerebral blood flow, neurologic deficit score, infarct volume, cerebral microvascular density, angiogenesis and neurogenesis were determined. We found: 1) The levels of plasma SDF-1α and circulating CD34+CXCR4+ cells were decreased in db/db mice; 2) The basal level of SDF-1α and MCAO-induced up-regulation of SDF-1α/CXCR4 axis were reduced in the brain of db/db mice; 3) Ad-CXCR4 transfection increased CXCR4 expression in EPCs and enhanced EPC colonic forming capacity; 4) Ad-CXCR4 transfection prevented EPCs from HG-induced dysfunction (migration and tube formation) and apoptosis via activation of PI3K/Akt/eNOS signal pathway; 4) Ad-CXCR4 transfection enhanced the efficacy of EPC infusion in attenuating infarct volume and promoting angiogenesis and neurogenesis. Our data suggest that Ad-CXCR4 primed EPCs have better therapeutic effects for ischemia stroke in diabetes than unmodified EPCs do.
format Online
Article
Text
id pubmed-3503762
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35037622012-11-26 Transfusion of CXCR4-Primed Endothelial Progenitor Cells Reduces Cerebral Ischemic Damage and Promotes Repair in db/db Diabetic Mice Chen, Ji Chen, Jianying Chen, Shuzhen Zhang, Cheng Zhang, Liangqing Xiao, Xiang Das, Avik Zhao, Yuhui Yuan, Bin Morris, Mariana Zhao, Bin Chen, Yanfang PLoS One Research Article This study investigated the role of stromal cell-derived factor-1α (SDF-1α)/CXC chemokine receptor 4 (CXCR4) axis in brain and endothelial progenitor cells (EPCs), and explored the efficacy of CXCR4 primed EPCs in treating ischemic stroke in diabetes. The db/db diabetic and db/+ mice were used in this study. Levels of plasma SDF-1α and circulating CD34+CXCR4+ cells were measured. Brain SDF-1α and CXCR4 expression were quantified at basal and after middle cerebral artery occlusion (MCAO). In in vitro study, EPCs were transfected with adenovirus carrying null (Ad-null) or CXCR4 (Ad-CXCR4) followed with high glucose (HG) treatment for 4 days. For pathway block experiments, cells were pre-incubated with PI3K inhibitor or nitric oxide synthase (NOS) inhibitor for two hours. The CXCR4 expression, function and apoptosis of EPCs were determined. The p-Akt/Akt and p-eNOS/eNOS expression in EPCs were also measured. In in vivo study, EPCs transfected with Ad-null or Ad-CXCR4 were infused into mice via tail vein. On day 2 and 7, the cerebral blood flow, neurologic deficit score, infarct volume, cerebral microvascular density, angiogenesis and neurogenesis were determined. We found: 1) The levels of plasma SDF-1α and circulating CD34+CXCR4+ cells were decreased in db/db mice; 2) The basal level of SDF-1α and MCAO-induced up-regulation of SDF-1α/CXCR4 axis were reduced in the brain of db/db mice; 3) Ad-CXCR4 transfection increased CXCR4 expression in EPCs and enhanced EPC colonic forming capacity; 4) Ad-CXCR4 transfection prevented EPCs from HG-induced dysfunction (migration and tube formation) and apoptosis via activation of PI3K/Akt/eNOS signal pathway; 4) Ad-CXCR4 transfection enhanced the efficacy of EPC infusion in attenuating infarct volume and promoting angiogenesis and neurogenesis. Our data suggest that Ad-CXCR4 primed EPCs have better therapeutic effects for ischemia stroke in diabetes than unmodified EPCs do. Public Library of Science 2012-11-21 /pmc/articles/PMC3503762/ /pubmed/23185548 http://dx.doi.org/10.1371/journal.pone.0050105 Text en © 2012 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Chen, Ji
Chen, Jianying
Chen, Shuzhen
Zhang, Cheng
Zhang, Liangqing
Xiao, Xiang
Das, Avik
Zhao, Yuhui
Yuan, Bin
Morris, Mariana
Zhao, Bin
Chen, Yanfang
Transfusion of CXCR4-Primed Endothelial Progenitor Cells Reduces Cerebral Ischemic Damage and Promotes Repair in db/db Diabetic Mice
title Transfusion of CXCR4-Primed Endothelial Progenitor Cells Reduces Cerebral Ischemic Damage and Promotes Repair in db/db Diabetic Mice
title_full Transfusion of CXCR4-Primed Endothelial Progenitor Cells Reduces Cerebral Ischemic Damage and Promotes Repair in db/db Diabetic Mice
title_fullStr Transfusion of CXCR4-Primed Endothelial Progenitor Cells Reduces Cerebral Ischemic Damage and Promotes Repair in db/db Diabetic Mice
title_full_unstemmed Transfusion of CXCR4-Primed Endothelial Progenitor Cells Reduces Cerebral Ischemic Damage and Promotes Repair in db/db Diabetic Mice
title_short Transfusion of CXCR4-Primed Endothelial Progenitor Cells Reduces Cerebral Ischemic Damage and Promotes Repair in db/db Diabetic Mice
title_sort transfusion of cxcr4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db/db diabetic mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503762/
https://www.ncbi.nlm.nih.gov/pubmed/23185548
http://dx.doi.org/10.1371/journal.pone.0050105
work_keys_str_mv AT chenji transfusionofcxcr4primedendothelialprogenitorcellsreducescerebralischemicdamageandpromotesrepairindbdbdiabeticmice
AT chenjianying transfusionofcxcr4primedendothelialprogenitorcellsreducescerebralischemicdamageandpromotesrepairindbdbdiabeticmice
AT chenshuzhen transfusionofcxcr4primedendothelialprogenitorcellsreducescerebralischemicdamageandpromotesrepairindbdbdiabeticmice
AT zhangcheng transfusionofcxcr4primedendothelialprogenitorcellsreducescerebralischemicdamageandpromotesrepairindbdbdiabeticmice
AT zhangliangqing transfusionofcxcr4primedendothelialprogenitorcellsreducescerebralischemicdamageandpromotesrepairindbdbdiabeticmice
AT xiaoxiang transfusionofcxcr4primedendothelialprogenitorcellsreducescerebralischemicdamageandpromotesrepairindbdbdiabeticmice
AT dasavik transfusionofcxcr4primedendothelialprogenitorcellsreducescerebralischemicdamageandpromotesrepairindbdbdiabeticmice
AT zhaoyuhui transfusionofcxcr4primedendothelialprogenitorcellsreducescerebralischemicdamageandpromotesrepairindbdbdiabeticmice
AT yuanbin transfusionofcxcr4primedendothelialprogenitorcellsreducescerebralischemicdamageandpromotesrepairindbdbdiabeticmice
AT morrismariana transfusionofcxcr4primedendothelialprogenitorcellsreducescerebralischemicdamageandpromotesrepairindbdbdiabeticmice
AT zhaobin transfusionofcxcr4primedendothelialprogenitorcellsreducescerebralischemicdamageandpromotesrepairindbdbdiabeticmice
AT chenyanfang transfusionofcxcr4primedendothelialprogenitorcellsreducescerebralischemicdamageandpromotesrepairindbdbdiabeticmice